Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 3.18% is 62% below its 5-year average of 8.29%, near the low end of its 5-year range (3.18%–12.08%).
As of the fiscal period ended Monday, June 30, 2025. 39.43% below its 12-month average of 5.25%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
3.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
5.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
8.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
8.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
10.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
13.32%
CURRENT VS TTM AVG
-39.43%
CURRENT VS 3Y AVG
-60.95%
CURRENT VS 5Y AVG
-61.66%
CURRENT VS 10Y AVG
-61.34%
CURRENT VS 15Y AVG
-71.03%
CURRENT VS 20Y AVG
-76.13%
SECTOR MEDIAN · HEALTHCARE
8.78%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
-63.78%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.30B
Return on Invested Capital (ROIC)
3.18%
TTM Avg
5.25%
3Y Avg
8.14%
5Y Avg
8.29%
Market Cap
$11.45B
Return on Invested Capital (ROIC)
10.58%
TTM Avg
10.99%
3Y Avg
9.48%
5Y Avg
9.31%
Market Cap
$10.21B
Return on Invested Capital (ROIC)
11.29%
TTM Avg
10.92%
3Y Avg
8.93%
5Y Avg
9.01%
Market Cap
$12.39B
Return on Invested Capital (ROIC)
9.94%
TTM Avg
9.96%
3Y Avg
10.13%
5Y Avg
11.66%
Market Cap
$10.16B
Return on Invested Capital (ROIC)
6.58%
TTM Avg
6.66%
3Y Avg
7.75%
5Y Avg
8.24%
Market Cap
$10.15B
Return on Invested Capital (ROIC)
7.64%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.02B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
12.65%
3Y Avg
8.97%
5Y Avg
7.27%
Market Cap
$9.76B
Return on Invested Capital (ROIC)
-10.90%
TTM Avg
-59.32%
3Y Avg
-58.49%
5Y Avg
-53.68%
Market Cap
$12.91B
Return on Invested Capital (ROIC)
2.82%
TTM Avg
2.97%
3Y Avg
3.42%
5Y Avg
5.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.30B | 3.18% | 5.25% | 8.14% | 8.29% |
| DaVita Inc. (DVA)vs › | $11.45B | 10.58% | 10.99% | 9.48% | 9.31% |
| Universal Health Services, Inc. (UHS)vs › | $10.21B | 11.29% | 10.92% | 8.93% | 9.01% |
| Align Technology, Inc. (ALGN)vs › | $12.39B | 9.94% | 9.96% | 10.13% | 11.66% |
| Henry Schein, Inc. (HSIC)vs › | $10.16B | 6.58% | 6.66% | 7.75% | 8.24% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | 7.64% | 12.01% | 15.07% | 15.28% |
| Insulet Corp. (PODD)vs › | $10.02B | 13.62% | 12.65% | 8.97% | 7.27% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -10.90% | -59.32% | -58.49% | -53.68% |
| Revvity, Inc. (RVTY)vs › | $12.91B | 2.82% | 2.97% | 3.42% | 5.50% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 2.04% | 2.21% | 2.35% | 2.39% |
ROIC
3.2%
ROE
5.3%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-06-30 | 3.18% |
| 2024-06-30 | 7.32% |
| 2023-06-30 | 9.99% |
| 2022-06-30 | 12.08% |
| 2021-06-30 | 10.47% |
| 2020-06-30 | 6.72% |
| 2019-06-30 | 6.00% |
| 2018-06-30 | 8.99% |
| 2017-06-30 | 5.85% |
| 2016-06-30 | 9.89% |
| 2015-06-30 | 10.00% |
| 2014-06-30 | 13.04% |
| 2013-06-30 | 14.88% |
| 2012-06-30 | 16.84% |
| 2011-06-30 | 18.51% |
| 2010-06-30 | 21.86% |
| 2009-06-30 | 22.37% |
| 2008-06-30 | 19.94% |
| 2007-06-30 | 18.73% |
| 2006-06-30 | 20.24% |
| 2005-06-30 | 22.91% |
| 2004-06-30 | 16.84% |
| 2003-06-30 | 17.42% |
| 2002-06-30 | 16.91% |
| 2001-06-30 | 16.27% |
| 2000-06-30 | 15.73% |
| 1999-06-30 | 14.56% |
| 1998-06-30 | 21.96% |
| 1997-06-30 | 21.27% |
| 1996-06-30 | 21.13% |
